Table 3.
Univariate | Multivariate | |||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
RRT during treatment | 2.59 (1.26–5.32) | 0.010 | 2.76 (1.04–7.36) | 0.043 |
High BAL NGAL (> 130 ng/ml) | 42.57 (1.62–1120.0) | 0.025 | ||
Age | 1.02 (1.00–1.05) | 0.053 | ||
SOFA | 1.19 (1.05–1.35) | 0.008 | ||
APACHE II | 1.05 (1.00–1.09) | 0.041 |
HR hazard ratio, CI confidence interval, RRT renal replacement therapy, NGAL neutrophil gelatinase-associated lipocalin, BAL bronchoalveolar lavage, SOFA sequential organ failure assessment, APACHE II Acute Physiology and Chronic Health Evaluation II.